Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark

By Sophia Carlsson

January 15, 2009 12:00 AM

The Norwegian pharmaceutical

company Pronova Biopharma has recruited 90 staff for its plant in Kalundborg which is set to become operational in a year's time. The company broke ground for a new DKK 1.5 billion factory in the Danish port town of Kalundborg in September 2007. The new plant in Denmark will enable the company to double its current production from 1 200 tons to 2 400 tons.

Pronova Biopharma’s

first commercialised omega-3 derived prescription product Omacor is a dietary adjunct for the treatment of elevated triglycerides, which are widely regarded as a risk factor for cardiovascular disease, especially in the overweight. Pronova Biopharma's omega-3 products are produced from fish oil from anchovies and sardines caught in the Pacific and Atlantic Oceans.

The siting of Pronova

Biopharma's factory in the same area of the country as Novo Nordisk, Novozymes, and their network of sub-suppliers, has benefited recruitment.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.